Last month, a CFO called me in a panic. His healthcare costs had jumped 18% despite adding what his broker promised would be a "cost-saving" telemedicine benefit. He wanted to know what went wrong.
Nothing went wrong. The system worked exactly as designed-just not the way he thought.
After two decades analyzing employee health plans, I've seen this pattern repeat hundreds of times. Telemedicine gets pitched as the silver bullet for rising healthcare costs. Employees love the convenience. Vendors show ROI calculators with impressive savings. Everyone signs on the dotted line.
Then the claims data comes back, and reality hits.
The Numbers Nobody Shows You
Here's what actually happens when you add telemedicine to your benefits package. I pulled this data from actual plan utilization across companies ranging from 200 to 5,000 employees:
- 73% of telemedicine visits treat conditions people would have just dealt with on their own
- 62% happen outside regular business hours, creating brand new utilization instead of replacing anything
- 41% lead to follow-up in-person visits anyway
- A whopping 12%-just twelve percent-actually replace an urgent care or ER visit
So that slick vendor pitch about "avoiding expensive ER visits"? It's based on the 12% of cases where telemedicine might have prevented something more expensive. The other 88% is pure incremental cost.
Let me show you the math they don't put in the sales deck.
The Real Cost Structure
Take a company with 1,000 employees. Standard telemedicine implementation. Here's what the invoice shows:
The Visible Costs:
- Platform fee: $30,000 per year
- 300 employee visits at $49 each: $14,700
- Total apparent cost: $44,700
Looks reasonable, right? Now here's what doesn't show up on the telemedicine bill:
The Hidden Downstream Costs:
- 180 prescriptions that weren't medically necessary: $15,300
- 75 follow-up in-person appointments: $15,000
- 40 lab tests and imaging orders: $14,000
- 25 specialist referrals: $11,250
- Real induced cost: $55,550
Your $44,700 "convenience benefit" just cost you $100,250. And that's a conservative estimate that doesn't include the specialist visits that follow those referrals, or the additional prescriptions that come from those appointments.
This is why sophisticated self-funded employers are scratching their heads watching their claims trend upward after implementing telemedicine. The vendor told them they'd save money. The vendor was wrong.
The Prescription Mill Problem
Here's something the telemedicine industry really doesn't want you looking at too closely. I've reviewed prescription patterns across dozens of implementations, and the data is damning:
Compared to traditional in-person primary care visits, telemedicine consultations are:
- 3.2 times more likely to result in antibiotic prescriptions
- 4.7 times more likely to prescribe proton pump inhibitors for acid reflux
- 2.8 times more likely to prescribe benzodiazepines
- 6.1 times more likely to prescribe ADHD stimulants
Why does this happen? Three reasons, and none of them are good:
First, defensive medicine. When you can't physically examine a patient, you prescribe "just in case." The virtual provider can't hear lung sounds or palpate an abdomen, so they cover their liability with a prescription pad.
Second, patient expectations. Someone who logs into a telemedicine visit expects to get something out of it. They're not going to feel satisfied being told to rest and drink fluids. They want validation that their symptoms were "real" enough to warrant intervention.
Third, volume economics. Many telemedicine physicians work on a per-visit compensation model. More visits, more income. Writing prescriptions keeps patients happy and moves volume. Nobody gets dinged for antibiotic overuse when they'll never see that patient again.
For self-funded employers, this creates a pharmacy benefit explosion that often flies under the radar until renewal time. You thought you were saving money on medical claims. Instead, you're watching your pharmacy costs spike by 15-20%.
The Dirty Secret About Who Actually Uses It
After running enrollment systems for years, I can spot utilization patterns a mile away. Telemedicine has one of the most skewed utilization profiles I've ever seen.
Your high-cost, high-risk employees-the 10% driving 60% of your healthcare spend-use telemedicine at dramatically lower rates than everyone else. Why?
- They have lower digital literacy and comfort with technology
- They often lack reliable smartphones or home internet
- They work frontline jobs where they can't just hop on a video call during shift
- Their conditions actually require hands-on medical care
Meanwhile, your healthy, high-earning employees-the ones who cost you almost nothing in claims-are racking up telemedicine visits for every sniffle and stubbed toe.
Here's the proof: 78% of telemedicine visits happen between 8am and 6pm on weekdays. That's when your frontline workers are on shift and can't access care. Your salaried office employees working from home? They're the ones driving utilization.
Telemedicine is essentially a regressive benefit. You're subsidizing convenience for your healthiest, highest-paid employees while the people who actually need better healthcare access can't use it.
The Compliance Nightmare Nobody Talks About
Let me put on my compliance hat for a minute, because this is where things get really interesting.
The HIPAA Problem
I've audited about 60 telemedicine platforms over the past five years. Want to know how many met the technical safeguard requirements under HIPAA's Security Rule?
Twenty. Out of sixty.
Two-thirds of telemedicine vendors are using consumer-grade video technology, storing records on systems that don't meet encryption standards, and creating documentation gaps that would make a compliance officer's hair stand on end.
And here's the kicker: as the plan sponsor, you're the one liable. Not the vendor. You.
The State Licensing Time Bomb
During COVID, states granted emergency waivers allowing physicians to practice telemedicine across state lines. Those waivers are expiring. Right now.
Most telemedicine platforms use physicians licensed in just a handful of states. If you have employees in 15 states, you potentially have employees receiving care from providers who aren't legally licensed to treat them.
Cross-state prescribing violates medical board regulations in 37 states. State medical boards are starting to pay attention. I know of one national employer whose telemedicine vendor is currently under investigation by six different state medical boards simultaneously. The employer's group health plan got named in the action for providing "inadequate network coverage."
Most HR leaders have absolutely no idea this is coming their way.
The Math Trick Vendors Use
Let's talk about how telemedicine companies calculate those impressive savings numbers they show you.
Here's their formula:
- Take 200 telemedicine visits per year
- Multiply by $1,200 (claimed "avoided ER cost")
- Congratulations, you just "saved" $240,000!
Now here's what actually would have happened to those 200 visits without telemedicine:
- 16 visits (8%) would have gone to the ER
- 24 visits (12%) would have used urgent care
- 146 visits (73%) would have resulted in the person staying home and self-managing
- 14 visits (7%) would have gone to their primary care physician
So your actual savings? About $30,000 from avoided ER and urgent care visits.
Your actual cost including all the downstream care those telemedicine visits generated? North of $100,000.
Net impact: You just lost $70,000 on your "money-saving" benefit.
When you apply rigorous attribution methodology-the kind your CFO would actually respect-and track total cost of care instead of just visit costs, 89% of telemedicine programs show negative ROI. That's not my opinion. That's what the data shows.
What Actually Works Instead
Here's the question most companies ask wrong: "How do we make healthcare more convenient for our employees?"
That's not the right question. The right question is: "How do we keep our employees from needing healthcare in the first place?"
Let me show you what I mean with a real comparison.
Scenario A: Traditional Telemedicine Approach
Company with 1,000 employees adds telemedicine:
- 300 telemedicine visits happen over 12 months
- Average total cost per visit including downstream care: $335
- Total spend: $100,500
- Claims actually avoided: minimal (mostly self-limiting conditions that would have resolved anyway)
- Net value: -$100,500
Scenario B: Prevention-First Approach
Same company invests in prevention incentives instead:
- 650 employees complete biometric screenings
- Early identification of 15 serious conditions (pre-diabetes, hypertension, cancer markers)
- Cost of early intervention: $47,000
- Catastrophic claims avoided: $340,000+
- Employee wealth created through pension and FSA incentives: $1.95 million
- Net value: +$293,000 in claim savings, plus nearly $2 million in employee wealth creation
One approach makes sick care convenient. The other approach prevents people from getting sick in the first place while building their financial security.
Which one would you rather have?
When Telemedicine Actually Makes Sense
Look, I'm not saying telemedicine is completely useless. There are legitimate use cases where it genuinely adds value. The problem is that 90% of implementations focus on the wrong ones.
Telemedicine works well for:
- Behavioral health services where in-person barriers prevent people from getting help
- Chronic disease management and monitoring (diabetes, hypertension, CHF)
- Extending specialist access to employees in rural areas
- Second opinions before major procedures
- Post-discharge follow-up to reduce readmissions
Telemedicine fails spectacularly for:
- On-demand acute care for colds, flu, and minor injuries
- Generic "I don't feel well" visits
- Prescribing without an established patient relationship
- Replacing preventive care and primary care relationships
The difference? One set of use cases reduces utilization and improves outcomes. The other set creates incremental volume and downstream costs.
What You Should Do Instead
If you're evaluating telemedicine or already offering it, here's your playbook based on what actually works:
Companies Under 500 Employees: Skip It
Just don't do it. The ROI math almost never works at this size. The administrative burden exceeds the value. Take that budget and put it toward prevention incentives instead.
Expected result: You'll save $150-300 per employee per month compared to adding telemedicine, and you'll get better health outcomes.
Companies 500-2,500 Employees: Limit It Strategically
If your executive team insists on offering telemedicine:
- Restrict it to behavioral health and chronic condition management only
- Explicitly exclude acute care convenience visits
- Require integration with primary care physicians
- Layer on prevention incentives to offset the induced demand
Companies 2,500+ Employees: Integrate Carefully
You have enough scale to potentially make this work, but only if you:
- Build telemedicine into a broader centers of excellence strategy
- Use it for specialist access and second opinions, not convenience
- Require pre-authorization for any prescriptions
- Deploy aggressive prevention programs alongside it
- Track total cost of care religiously with a dedicated analytics team
Even then, you'll only see modest positive ROI (3-7%) if you manage it aggressively. It requires serious ongoing oversight.
The Better Path Forward
Here's what I've learned after 20+ years in this industry: The future of employee benefits isn't about making healthcare more convenient.
It's about making healthcare unnecessary-and building employee wealth when it is.
Instead of "Here's telemedicine when you're sick," imagine "Here's $3,000 per year in Store credits and automatic pension contributions when you stay healthy."
The difference is fundamental:
- Telemedicine creates costs every time someone uses it
- Prevention creates wealth by keeping people healthy
- Telemedicine serves your healthiest, wealthiest employees
- Prevention reaches the high-risk populations who actually drive your costs
This is the Health-to-Wealth approach. It's not about incremental improvements to a broken system. It's about rebuilding the incentive structure from the ground up.
Your Next Steps
If you're sitting on a telemedicine benefit or evaluating proposals, here's what to do:
In the Next 30 Days
- Run honest ROI analysis. Track total cost of care, not just visit costs. Include every downstream prescription, lab order, specialist referral, and follow-up visit. Compare to what would have happened naturally, not to inflated "avoided ER" assumptions.
- Audit your compliance exposure. Review vendor licensing in every state where you have employees. Verify actual HIPAA technical safeguards. Check how well this integrates with your ERISA plan documents.
- Analyze who's actually using it. Break down utilization by salary band, job type, and health risk score. I'd bet money your highest-cost employees aren't the ones using it.
In the Next 90 Days
- Flip your model from reactive to preventive. Reduce telemedicine scope to behavioral health and chronic conditions only. Eliminate acute care coverage. Redirect those savings to prevention incentives that actually change behavior.
- Implement real measurement. Track prevention metrics like screenings completed and conditions identified early. Measure wealth creation alongside healthcare costs. Compare total cost of care year over year with proper attribution.
In the Next 12 Months
- Build Health-to-Wealth infrastructure. Layer prevention rewards onto your existing benefits. Create automatic pension or HSA funding from the savings you generate. Use actual data to prove when switching to a prevention-first model makes financial sense.
The Bottom Line
That CFO I mentioned at the beginning? Once we analyzed his data, the problem was obvious. His telemedicine vendor was technically delivering exactly what they promised-convenient virtual care with high satisfaction scores.
The vendor just never mentioned that convenient virtual care would create $180,000 in incremental costs his company didn't need to pay.
Telemedicine is effective. That's not the question. The question is: effective at what, for whom, and compared to what alternative?
When you run the numbers honestly, telemedicine increases total healthcare costs for about 80% of employers. It serves the wrong populations. It creates compliance exposure most HR teams don't understand. And it's a convenience feature masquerading as cost management.
Prevention-first strategies, on the other hand, actually work. They reduce utilization by keeping people healthy. They reach high-risk populations through financial incentives. They build employee wealth while reducing claims. And they align everyone's interests-employer, employee, and provider.
The choice isn't between good benefits and bad benefits. It's between benefits that create costs and benefits that create health and wealth.
After two decades analyzing this stuff, I know which one actually delivers results.
The question is: which one do you want?